表紙
市場調查報告書

COVID-19 (新型冠狀病毒感染疾病) - 開發平台(管線)的考察:2020年

COVID-19 (CoronaVirus) - Pipeline Insight, 2020

出版商 DelveInsight Business Research LLP 商品編碼 939927
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
COVID-19 (新型冠狀病毒感染疾病) - 開發平台(管線)的考察:2020年 COVID-19 (CoronaVirus) - Pipeline Insight, 2020
出版日期: 2020年04月01日內容資訊: 英文 90 Pages
簡介

本報告提供COVID-19 (新型冠狀病毒感染疾病) 治療藥調查分析,提供目前方案和成長預測相關的系統性資訊。

目錄

第1章 報告的簡介

第2章 COVID-19(新型冠狀病毒感染疾病):疾病概要

第3章 開發平台(管線)預測

  • COVID-19開發中產品的概要

第4章 比較分析

第5章 COVID-19臨床階段的治療產品

  • 醫藥品:企業
    • 產品說明
    • 研究開發
    • 產品開發活動
  • 其他的產品簡介

第6章 COVID-19非臨床階段的治療產品

  • 醫藥品:企業
    • 產品說明
    • 研究開發
    • 產品開發活動
  • 其他的產品簡介

第7章 治療開發平台分析

  • 開發平台分析:各給藥途徑
  • 開發平台分析:各階段·給藥途徑
  • 開發平台分析:各分子類型
  • 開發平台分析:各階段·分子類型

第8章 暫停中的開發中產品

  • 醫藥品的說明
    • 研究開發
    • 產品開發活動
    • 休止/中止的理由

第9章 附錄

第10章 調查手法

第11章 諮詢服務

第12章 免責聲明

第13章 關於DelveInsight

目錄

"COVID-19(CoronaVirus) - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across COVID-19 (CoronaVirus). A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type.

Products covered by Phase

  • Phase III, Phase II, Phase I
  • Pre-clinical & Discovery
  • Inactive (Discontinued and Dormant)

Overview of pipeline development activities for COVID-19(CoronaVirus)

Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

Therapeutic segmentation of products for COVID-19(CoronaVirus)

The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight's team of industry experts.

Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report

  • Provides an overview of therapeutic pipeline activity for COVID-19(CoronaVirus) across the complete product development cycle including all clinical and non-clinical stages
  • It comprises of detailed profiles of COVID-19(CoronaVirus) therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
  • Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
  • Coverage of dormant and discontinued pipeline projects across COVID-19(CoronaVirus)

Reasons to Buy

  • Establish a comprehensive understanding of the current pipeline scenario across COVID-19(CoronaVirus) to formulate effective R&D strategies
  • Assess challenges and opportunities that influence COVID-19(CoronaVirus) R&D
  • Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
  • Identify the relationship between the product and use it for target finding, drug repurposing, and precision medicine
  • Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for COVID-19(CoronaVirus) to enhance and expand business potential and scope
  • Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

Table of Contents

1. Report Introduction

2. COVID-19(CoronaVirus) - Disease Overview

3. Pipeline Outlook

  • An Overview of Pipeline Products for COVID-19(CoronaVirus)

4. Comparative Analysis

5. COVID-19(CoronaVirus) Therapeutic Products in Clinical Stage

  • 5.1 Drug Name : Company Name
    • Product Description
    • Research and Development
    • Product Development Activities
  • Other product profiles in the detailed report.....

6. COVID-19(CoronaVirus) Therapeutic Products in Non-clinical Stage

  • 6.1 Drug Name : Company Name
    • Product Description
    • Research and Development
    • Product Development Activities
  • Other product profiles in the detailed report.....

7. Therapeutic Pipeline Analysis

  • Pipeline Analysis by Route of Administration
  • Pipeline Analysis by Stage and Route of Administration
  • Pipeline Analysis by Molecule Type
  • Pipeline Analysis by Stage and Molecule Type

8. Inactive Pipeline Products

  • 8.1 Drug Description
    • Research and Development Studies
    • Product Development Activities
    • Reason for dormancy/discontinuation

9. Appendix

10. Report Methodology

11. Consulting Services

12. Disclaimer

13. About DelveInsight

Note: Certain sections of the table of contents would vary according to the availability of information.

List Of Tables

  • Table 1: Total Pipeline Products for COVID-19(CoronaVirus)
  • Table 2: COVID-19(CoronaVirus) Therapeutic Products in Clinical Stage
  • Table 3: COVID-19(CoronaVirus) Therapeutic Products in Non-clinical Stage
  • Table 4: Pipeline Analysis by Route of Administration
  • Table 5: Pipeline Analysis by Stage and Route of Administration
  • Table 6: Pipeline Analysis by Molecule Type
  • Table 7: Pipeline Analysis by Stage and Molecule Type
  • Table 8: Inactive Products

List Of Figures

  • Figure 1: Total Products for COVID-19(CoronaVirus)
  • Figure 2: COVID-19(CoronaVirus) Therapeutic Products in Clinical Stage
  • Figure 3: COVID-19(CoronaVirus) Therapeutic Products in Non-clinical Stage
  • Figure 4: Pipeline Analysis by Route of Administration
  • Figure 5: Pipeline Analysis by Stage and Route of Administration
  • Figure 6: Pipeline Analysis by Molecule Type
  • Figure 7: Pipeline Analysis by Stage and Molecule Type
  • Figure 8: Inactive Products